Health News Releases

  • Today January 24
Ribbon Cutting of the Lab (Photo: Business Wire)
November 22, 2024 16:40
Rigaku BioScience Lab Opens in USA
Rigaku Corporation, a Rigaku Holdings Group company that serves as a global solution partner for X-ray analytical equipment (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), opened Rigaku
November 22, 2024 10:50
Global Cell and Gene Therapy Trials: Driving Innovation in Oncology and Beyond
Novotech, the global full-service clinical Contract Research Organization (CRO), has published its latest whitepaper, offering in-depth analysis and emerging trends and advancements within the rapidly
November 22, 2024 09:55
The Future of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights from Global Research
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, sh
November 21, 2024 11:40
Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology Advancement
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
November 20, 2024 17:10
NationsBenefits Acquires Good Measures to Revolutionize Food as Medicine Solutions
NationsBenefits®, the leading fintech, benefits, and outcomes platform for healthcare, announced the acquisition of Good Measures, the leading platform for Food as Medicine supporting health plans and
November 20, 2024 15:30
Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites
Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, has today announced the expansion of its o
November 19, 2024 15:50
HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study
HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients were enrolled in their novel prospective master protocol study, called BOOMBOX, design
November 19, 2024 11:35
Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung Cancer (SCLC)
Novotech, the global full-service clinical Contract Research Organization (CRO), has published a new report, Small Cell Lung Cancer: Global Clinical Trial Landscape 2024 (https://cts.businesswire.com/
(Graphic: Business Wire)
November 17, 2024 15:40
BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer
BeiGene, Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54152783&newsitemid=20241114671168&lan=en-US&anchor=BeiGene&index=1&md5=e4496ffaca181720a54a2
The structural model of amorphous carbon (left), estimated by TXS-RMC using SmartLab (right) (Graphi
November 15, 2024 16:00
Rigaku Develops Technology for 3D Visualization of the Atomic-scale Structure of Amorphous Carbon
The X-ray Laboratory of Rigaku Corporation, a Rigaku Holdings Group company and a global solution partner for X-ray analysis (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”),
(Graphic: Business Wire)
November 15, 2024 13:50
BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54150961&newsitemid=20241112799807&lan=en-US&anchor=BeiGene&index=1&md5=4e5a672b984a991400376fd3071
November 15, 2024 11:10
Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54151986&newsitemid=20241112190210&lan=en-US&anchor=Medidata&index=1&md5=13f9038490d8f84d037
The new QPS Cell Therapy Unit in Springfield, Missouri is a Leukopak collection and blood product pr
November 14, 2024 14:00
QPS Launches New Leukopak and Cell Therapy Products Facility
QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy business unit. The unit’s first achievement is the opening of a new Leukopak collection a
November 14, 2024 11:10
Center for Disease Analysis Foundation Receives $7 Million Grant from the John C. Martin Foundation to Support the Polaris Observatory
The Center for Disease Analysis (CDA) Foundation is pleased to announce receipt of a $7 million grant from the John C. Martin Foundation to sustain and expand the Polaris Observatory until the end of
November 14, 2024 10:30
Novotech Releases In-Depth Report on Cervical Cancer: Addressing a Global Health Challenge
Novotech, the global full-service clinical Contract Research Organization (CRO), has released a new report, Cervical Cancer - Global Clinical Trial Landscape (https://cts.businesswire.com/ct/CT?id=sma
November 13, 2024 15:50
Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54151261&newsitemid=20241112963841&lan=en-US&anchor=Medidata&index=1&md5=1aed735279447556547
November 13, 2024 11:35
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion
November 13, 2024 10:55
Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that IDEAYA Biosciences, Inc.
Novotech and Biostar Pharma Partnership (Photo: Business Wire)
November 13, 2024 08:58
Novotech and Biostar Establish Strategic Partnership Following Biostar’s HKEX Listing
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
November 12, 2024 15:38
Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial
Merck, a leading science and technology company, today announced that the Phase III MANEUVER trial of pimicotinib, an investigational medicine being developed by Abbisko Therapeutics Co., Ltd., met it
November 12, 2024 10:30
Huonslab reinforces HyDIFFUZE™ (Recombinant human hyaluronidase PH20) Intellectual Property by completing the US and EU Examination Request under PCT application.
Huonslab, Co. Ltd. (https://huonslab.com/layout/eng/home.php?go=main&) S. Korea, a subsidiary of Huons Global (https://huonsglobal.com/eng/home.php) (KOSDAQ:084110) and a global leader in recombinant
2024 Clinical Trials Arena Excellence Award Winner Presented to Novotech (Graphic: Business Wire)
November 12, 2024 09:45
Novotech Recognized for Excellence in Business Expansion, Innovation, and Marketing at the 2024 Clinical Trials Arena Excellence Awards
Novotech, the global full-service clinical Contract Research Organization (CRO), has received multiple awards in the 2024 Clinical Trials Arena Excellence Awards, recognizing the achievements of our p
November 08, 2024 16:10
Huons Speeds up Biopharmaceutical Development with Human-Derived Hyaluronidase and Expands Bio-Pharma Business by Acquiring Stake in PanGen
Huons Co., Ltd. (https://www.huons.com/eng/home.php?go=main)(KRX:243070) (Co-CEOs : Song Soo-young and Yoon Sang-bae) announced on November 5 that it has decided to acquire 2,647,378 shares of PanGen
SBC Medical Group Holdings Incorporated, a global owner, operator and provider of management service
November 08, 2024 15:15
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”, or the “Company”, or “SBC”), a global owner, operator and provider of management services and products to cosmetic treatment cente
November 07, 2024 10:15
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Brut
25 per page50 per page75 per page100 per page